(Q47987021)

7 February 2018

title

Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: a pilot study (English)

1 reference

7 February 2018

1 reference

temporal lobe epilepsy

1 reference

4

Michael R Sperling

1 reference

7 February 2018

Ali A Asadi-Pooya

1

1 reference

7 February 2018

S Mohammad Ali Razavizadegan

series ordinal

2

1 reference

7 February 2018

Alireza Abdi-Ardekani

series ordinal

3

1 reference

7 February 2018

publication date

22 August 2013

1 reference

7 February 2018

published in

Epilepsy Behavior

1 reference

7 February 2018

volume

29

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

150-154

1 reference

7 February 2018

Reasons for uncontrolled seizures in adults; the impact of pseudointractability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Reasons for uncontrolled seizures in children: the impact of pseudointractability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

New drugs for the treatment of epilepsy: a practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

MDR1 gene expression in brain of patients with medically intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Significance of MDR1 and multiple drug resistance in refractory human epileptic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

How to explain multidrug resistance in epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Verapamil treatment for women with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Calcium channel blockers in psychiatric disorders: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Diverse mechanisms of antiepileptic drugs in the development pipeline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Efficacy of new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Potentiation of anti-epileptic drugs effectiveness by pyronaridine in refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

Calcium antagonists in cardiology: Update on sustained-release drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.006

10.1016/J.YEBEH.2013.07.006

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018